crixivan
Pharmaranks rates Crixivan 3.6/5 for recall safety — an independent score from its FDA recall history and its manufacturer's record. Crixivan (Indinavir Sulfate) is a medication used to treat Acquired Immunodeficiency Syndrome.
Indinavir Sulfate · by Merck Sharp Dohme
Based on 1 source · Recall-safety score from FDA recall history — this product's own recalls and its manufacturer's record. Not an efficacy or quality rating. methodology →
Key facts
- Active ingredient
- Indinavir Sulfate
- Form
- Capsule
- Strength
- Indinavir Sulfate EQ 100MG Base · Indinavir Sulfate EQ 200MG Base · Indinavir Sulfate EQ 333MG Base · Indinavir Sulfate EQ 400MG Base
- Type
- Prescription (Rx)
- Brand or generic
- Brand-name
- May treat
- acquired immunodeficiency syndrome
- Manufacturer
- Merck Sharp Dohme
- FDA application
- NDA020685
- Availability
- Discontinued (per FDA)
May treat (source: NIH RxClass)
Dosage forms
Capsule
The forms currently marketed in the U.S., per the FDA National Drug Code Directory.
Ways to save
Ask for the generic
Same active ingredient, far cheaper. Is there a generic? →
Request a 90-day supply
Bulk fills usually lower the per-dose price vs monthly refills.
Use copay cards
Manufacturer copay cards & patient-assistance programs — especially for brand drugs.
Compare alternatives
A same-class option may cost less. See alternatives →
Frequently asked questions
- What does Crixivan treat?
- Crixivan (Indinavir Sulfate) may be used to treat acquired immunodeficiency syndrome, based on NIH RxClass drug-classification data (conditions a drug may treat — not a verbatim copy of the FDA-approved label). This is general reference, not medical advice.
- How is Crixivan rated?
- pharmaranks gives Crixivan a composite score of 3.6 out of 5, currently based on 1 weighted source (FDA regulatory recall-safety data weighted highest). See our methodology at /how-we-rate.
- Is there a coupon or discount for Crixivan?
- pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Crixivan. To pay less, ask your prescriber or pharmacist whether a generic equivalent exists, check the manufacturer's copay/savings card and patient-assistance program, and compare a pharmacy discount card against your insurance copay. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.
- Who makes Crixivan?
- Crixivan is marketed by Merck Sharp Dohme. You can see Merck Sharp Dohme's full profile, rating, and other products on pharmaranks.
- Is Crixivan a brand-name or generic drug?
- Crixivan is a brand-name product with the active ingredient Indinavir Sulfate.
- Is Crixivan available over the counter?
- No. Crixivan is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.
- What forms does Crixivan come in?
- Crixivan is currently marketed as capsule, per the FDA's National Drug Code Directory.
- Is Crixivan FDA-registered?
- Crixivan is on record with the U.S. FDA under application number NDA020685. You can verify this on its official FDA label.
- Has Crixivan been recalled by the FDA?
- Crixivan has no FDA recalls recorded under its own application in the openFDA enforcement database. Its recall-safety score reflects its manufacturer's overall recall record. This is general reference, not medical advice — check the FDA recall database for the latest alerts.
- Is Crixivan safe?
- There's no single safe-or-not verdict. pharmaranks gives Crixivan a recall-safety score of 72/100, based on its FDA recall history (no recalls under its own FDA application) — not an efficacy or side-effect rating. Review its FDA-label side effects and warnings before use, and always consult a licensed professional.
Information is sourced from public FDA regulatory data. Provided for general reference only — not medical advice. Always consult a licensed professional and the current prescribing information.
What people report to the FDA about INDINAVIR SULFATE
The FDA Adverse Event Reporting System (FAERS) collects reports from patients and clinicians. It holds 346 reports naming INDINAVIR SULFATE — the active ingredient in Crixivan, and the FDA flagged 97% of those reports as serious. The effects reported most often — leaving out reports about overdose, misuse or the condition being treated, which dominate the raw list for common medicines:
- lipodystrophy acquired156 reports
- eyelid ptosis153 reports
- diplopia151 reports
- mitochondrial toxicity151 reports
- dysphagia78 reports
- progressive external ophthalmoplegia75 reports
- ophthalmoplegia53 reports
- vomiting44 reports
Read these as a signal, not a rate. A report does not mean INDINAVIR SULFATE caused the effect — anyone can file one, and many describe people taking several medicines for several conditions. Crucially there is no denominator: FAERS does not record how many people took the drug, so these counts cannot be turned into “X% of patients” — a bigger number often just means a more widely used or more talked-about drug. Duplicates exist, and publicity drives reporting. For what is actually established, read the FDA label.
Source: openFDA drug/event (FAERS), retrieved September 25, 2026.
Reviews
No reviews yet. Be the first to write one.
People also viewed
aptivus
Tipranavir
reyataz
Atazanavir Sulfate
vemlidy
Tenofovir Alafenamide Fumarate
viread
Tenofovir Disoproxil Fumarate
lamivudine
Lamivudine
nevirapine
Nevirapine
Compare Crixivan head-to-head
Browse medications A–Z
Research products from A to Z, compare independent ratings, and find alternatives.
crixivan
72/100